Silicon alleviates nonalcoholic steatohepatitis by reducing apoptosis in aged wistar rats fed a high-saturated fat, high-cholesterol diet

Journal of Nutrition

Volumn 147, Issue 6, 2017, Pages 1104-1112

  Garcimartín, Alba ^a   López Oliva, M Elvira ^a   Sántos López, Jorge A ^a   García Fernández, Rosa A ^b   Macho González, Adrián ^a   Bastida, Sara ^a   Benedí, Juana ^a   Sánchez Muniz, Francisco J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Aging; Lipoapoptosis; NAFLD; NASH; Si enriched restructured pork; Wistar rats

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; APOPTOSIS INDUCING FACTOR; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CASPASE 9; CYTOCHROME C; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; PROTEIN BAX; PROTEIN BCL 2; SATURATED FATTY ACID; SILICON; BIOLOGICAL MARKER; CHOLESTEROL INTAKE; SILICON DIOXIDE; TRACE ELEMENT;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; FOOD INTAKE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER CELL; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; RAT; TUNEL ASSAY; WESTERN BLOTTING; ADMINISTRATION AND DOSAGE; ANIMAL; CHOLESTEROL INTAKE; DRUG EFFECTS; LIPID DIET; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PIG; RED MEAT; WISTAR RAT;

ANIMALS; APOPTOSIS; BIOMARKERS; CHOLESTEROL, DIETARY; DIET, HIGH-FAT; LIVER; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; RATS, WISTAR; RED MEAT; SILICON; SILICON DIOXIDE; SWINE; TRACE ELEMENTS;

EID: 85021077905     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.116.243204     Document Type: Article

References (38)

1. Loguercio C, De Simone T, D'Auria MV, de Sio I, Federico A, Tuccillo C, Abbatecola AM, Del Vecchio Blanco C. Non-alcoholic fatty liver disease: a multicenter clinical study by the Italian Association for the Study of the liver. Dig Liver Dis 2004;36:398-405
2. Pan M, Song YL, Xu JM, Gan HZ. Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats. J Pineal Res 2006;41:79-84
3. Feldstein AE, Gores GJ. Apoptosis in alcoholic and nonalcoholic steatohepatitis. Front Biosci 2005;10:3093-9
4. Takahashi Y, Soejima Y, Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2012;18:2300-8
5. Celada P, Bastida S, Sánchez-Muniz FJ. To eat or not to eat meat. That is the question. Nutr Hosp 2016;33:177-81
6. Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation 2008;117:754-61
7. Olmedilla-Alonso B, Jiménez-Colmenero F, Sánchez-Muniz FJ. Development and assessment of healthy properties of meat and meat products designed as functional foods. Meat Sci 2013;95:919-30
8. Schultz Moreira AR, Olivero-David R, Vázquez-Velasco M, Gonźalez-Torres L, Benedí J, Bastida S, Sánchez-Muniz FJ. Protective effects of sea spaghetti-enriched restructured pork against dietary cholesterol: effects on arylesterase and lipoprotein profile and composition of growing rats. J Med Food 2014;17:921-8
9. Jurkić LM, Cepanec I, Pavelić SK, Pavelić K. Biological and therapeutic effects of ortho-silicic acid and some ortho-silicic acid-releasing compounds: new perspectives for therapy. Nutr Metab (Lond) 2013;10:2
10. Jugdaohsingh R, Sripanyakorn S, Powell JJ. Silicon absorption and excretion is independent of age and sex in adults. Br J Nutr 2013; 110:1024-30
11. Garcimartín A, Merino JJ, Gonźalez MP, Sánchez-Reus MI, Sánchez-Muniz FJ, Bastida S, Benedí J. Organic silicon protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide effects. BMC Complement Altern Med 2014;14:384
12. Garcimartín A, Merino JJ, Santos-López JA, López-Oliva ME, Gonźalez MP, Sánchez-Muniz FJ, Benedí J. Silicon as neuroprotector or neurotoxic in the human neuroblastoma SH-SY5Y cell line. Chemosphere 2015;135:217-24
13. Garcimartín A, Santos-López JA, Bastida S, Benedí J, Sánchez-Muniz FJ. Silicon-enriched restructured pork affects the lipoprotein profile, VLDL oxidation, and LDL receptor gene expression in aged rats fed an atherogenic diet. J Nutr 2015;145:2039-45
14. Santos-López JA, Garcimartín A, Merino P, López-Oliva ME, Bastida S, Benedí J, Sánchez-Muniz FJ. Effects of silicon vs. hydroxytyrosolenriched restructured pork on liver oxidation status of aged rats fed high-saturated/high-cholesterol diets. PLoS One 2016;11:e0147469
15. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21
16. Gavrieli Y, Sherman Y, Ben-Sasso SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501
17. Exley C. Silicon in life: a bioinorganic solution to bioorganic essentiality. J Inorg Biochem 1998;69:139-44
18. Floreani A. Liver diseases in the elderly: an update. Dig Dis 2007; 25:138-43
19. Regev A, SchiffER. Liver disease in the elderly. Gastroenterol Clin North Am 2001;30:547-63
20. Gupte AA, Liu JZ, Ren Y, Minze LJ, Wiles JR, Collins AR, Lyon CJ, Pratico D, Finegold MJ, Wong ST, et al. Rosiglitazone attenuates ageand diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice. Hepatology 2010;52:2001-11
21. Sheedfar F, Di Biase S, Koonen D, Vinciguerra M. Liver diseases and aging: friends or foes? Aging Cell 2013;12:950-4
22. Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, Lütjohann D, Kerksiek A, van Kruchten R, Maeda N, Staels B, et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 2008;48:474-86
23. Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 2006;87:1-16
24. Savard C, Tartaglione EV, Kuver R, Haigh WG, Farrell GC, Subramanian S, Chait A, Yeh MM, Quinn LS, Ioannou GN. Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. Hepatology 2013;57:81-92
25. Subramanian S, Goodspeed L, Wang S, Kim J, Zeng L, Ioannou GN, Haigh WG, Yeh MM, Kowdley KV, O'Brien KD, et al. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. J Lipid Res 2011;52:1626-35
26. Brunt EM. Histopathology of non-alcoholic fatty liver disease. Clin Liver Dis 2009;13:533-44
27. Cazanave SC, Gores GJ. Mechanisms and clinical implications of hepatocyte lipoapoptosis. Clin Lipidol 2010;5:71-85
28. Malhi H, Gores GJ. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis 2008;28:360-9
29. Ramadori P, Kroy D, Streetz KL. Immunoregulation by lipids during the development of non-alcoholic steatohepatitis. Hepatobiliary Surg Nutr 2015;4:11-23
30. Nassir F, Ibdah JA. Role of mitochondria in nonalcoholic fatty liver disease. Int J Mol Sci 2014;15:8713-42
31. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006;6:1-28
32. Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 2012;142:711-25.e6
33. Zhu C, Xie P, Zhao F, Zhang L, An W, Zhan Y. Mechanism of the promotion of steatotic HepG2 cell apoptosis by cholesterol. Int J Clin Exp Pathol 2014;7:6807-13
34. Yetti H, Naito H, Jia X, Shindo M, Taki H, Tamada H, Kitamori K, Hayashi Y, Ikeda K, Yamori Y, et al. High-fat-cholesterol diet mainly induced necrosis in fibrotic steatohepatitis rat by suppressing caspase activity. Life Sci 2013;93:673-80
35. Li T, Chiang JY. Regulation of bile acid and cholesterol metabolism by PPARs. PPAR Res 2009;2009:501739
36. Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006;44:27-33
37. Wang K. Molecular mechanisms of hepatic apoptosis. Cell Death Dis 2014;5:e996
38. Borghi-Scoazec G, Scoazec JY, Durand F, Bernuau J, Belghiti J, Feldmann G, Henin D, Degott C. Apoptosis after ischemia-reperfusion in human liver allografts. Liver Transpl Surg 1997;3:407-15